3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
3
Active not recruiting
2
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
31
Squamous Cell Carcinoma of Head and Neck
22
Carcinoma, Non-Small-Cell Lung
20
Breast Neoplasms
18
Neoplasms
17
Glioblastoma
17
Esophageal Squamous Cell Carcinoma
16
Rectal Neoplasms
15
Esophageal Neoplasms
15
Lung Neoplasms
14
Head and Neck Neoplasms
13
Uterine Cervical Neoplasms
11
Neoplasm Metastasis
10
Glioma
10
Oropharyngeal Neoplasms
8
Nasopharyngeal Carcinoma
8
Stomach Neoplasms
7
Radiation Injuries
7
Brain Neoplasms
7
Hyperthermia
6
Carcinoma, Hepatocellular
6
Astrocytoma
6
Urinary Bladder Neoplasms
5
Small Cell Lung Carcinoma
5
Sarcoma
5
Oligodendroglioma
5
Colorectal Neoplasms
5
Carcinoma, Renal Cell
5
Triple Negative Breast Neoplasms
4
Pancreatic Neoplasms
4
Interventions
Temozolomide
3
Cyclophosphamide
3
Etoposide
2
ibrutinib
1
gallium Ga 68 dotatate
1
fludarabine
1
etoposide phosphate
1
belzutifan
1
Zoledronic Acid
1
Vincristine
1
Thiotepa
1
Tamoxifen
1
Standard of Care
1
Radiotherapy
1
ONC206
1
Nivolumab
1
Mesna
1
Isotretinoin
1
Hydrocortisone
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Eflornithine
1
Drug Therapy
1
Cisplatin
1
Celecoxib
1
Carboplatin
1
Blood Specimen Collection
1
Automobiles
1
1-methyltryptophan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Neuroectodermal Tumors, Primitive
×
Radiotherapy
×
Clear all
NCT06861244
2026-04-23
PNOC031
University of California, San Francisco
Phase 2
Recruiting
70 enrolled